I-Elthrombopag igama elijwayelekile legama lokuhweba lesidakamizwa i-Promacta. Kwezinye izimo, ochwepheshe bezokunakekelwa kwempilo bangasebenzisa igama lokuhweba, i-Promacta, uma bebhekisela egameni lesidakamizwa esijwayelekile, i-eltrombopag.

Lo muthi usetshenziselwa ukwelapha amazinga aphansi e-platelet kubantu abanesifo esithile segazi esibizwa ngokuthi yi-chronic immune (idiopathic) thrombocytopenia purpura (ITP) noma abane-hepatitis C engapheli. Ingase futhi isetshenziselwe ukwelapha abantu abanokuphazamiseka okuthile kwegazi (i-aplastic i-anemia).

I-Elthrombopag isetshenziselwa ukuvimbela iziqephu zokuphuma kwegazi kubantu abadala nasezinganeni ezineminyaka engu-1 nangaphezulu, ezingaphelii-immune thrombocytopenic purpura(I-ITP). I-ITP yisimo sokopha esibangelwa ukuntuleka kwama-platelet egazini.

I-Elthrombopag ayilona ikhambi le-ITP futhi ngeke yenze ukubalwa kweplatelet yakho kube ngokwejwayelekile uma unalesi simo.

I-Eltrombopag iphinde isetshenziselwe ukuvimbela ukopha kubantu abadala abane-hepatitis C engapheli abaphathwa nge-interferon (njenge-Intron A, Infergen, Pegasys, PegIntron, Rebetron, Redipen, noma Sylatron).

I-Elthrombopag nayo isetshenziswa kanye neminye imithi yokwelapha okunzimai-anemia ye-aplastickubantu abadala nasezinganeni okungenani ezineminyaka emi-2 ubudala.

Ngezinye izikhathi i-Elthrombopag inikezwa ngemva kokuba ezinye izindlela zokwelapha zehlulekile.

I-Eltrombopag ayisetshenziselwa ukwelapha i-myelodysplastic syndrome (ebizwa nangokuthi "preleukemia").

I-Elthrombopag ingase isetshenziselwe izinjongo ezingabaliwe kulo mhlahlandlela wemithi.